Delivering Results in Executive Search: Our Proven Track Record

Share this Article
Back to Blogs

Delivering Results in Executive Search: Our Proven Track Record

At Allerton Bishop, we don’t just fill roles — we build leadership teams that transform pharmaceutical businesses.

As a boutique executive search firm focused exclusively on the pharmaceutical sector, we take pride in our strategic, high-touch approach to recruitment. Our mission is simple: connect pioneering organisations with exceptional talent, and do so with precision, discretion, and integrity.

 

A Track Record That Speaks for Itself

 

- Vice President, Manufacturing & Supply – Gene therapy biotech, Switzerland
  💼 Appointed on CHF 260,000

- Site Quality Director – Pharmaceutical contract manufacturing, Finland
  💼 Appointed on €130,000

- Vice President, Process Development – Gene therapy biotech, UK (Phase I)
  💼 Appointed on £140,000

- Global Market Access Director – Mid-cap pharma, Italy (Pain therapeutics)
  💼 Appointed on €125,000

- Senior Commercial Director - Europe – Specialty care pharma, UK
  💼 Appointed on £135,000

- Managing Director – CDMO, Cell & Gene Therapy, UK
  💼 Appointed on £150,000

- Vice President, Site Operations – Pharma CDMO, Northern Germany
  💼 Appointed on €170,000

- Quality Director & QP – Generics, Ireland
  💼 Appointed on €180,000

- Chief Development Officer – Gene therapy biotech (mid-clinical), Netherlands
  💼 Appointed on €220,000

 

Let’s Start a Conversation

We work with ambitious biotech and pharma companies that need leadership talent with vision, precision, and credibility. If you’re ready to build your executive team — or you’re a leader ready for a new challenge — let’s connect.

Andrew Davis
Founder, Allerton Bishop
📧 andrew.davis@allertonbishop.co.uk
📞 +44 (0)7958 109399
🌐 www.allertonbishop.co.uk

Post Comment

*
*
*
2026 Shifting Global Hiring Investment

2026 Shifting Global Hiring Investment

by Andrew Davis

As 2026 gathers momentum, a clear shift is emerging across the US, UK, Germany and Switzerland

The UK Doesn’t Have a Talent Problem — It Has a Strategy Problem

The UK Doesn’t Have a Talent Problem — It Has a Strategy Problem

by Andrew Davis

The UK Doesn’t Have a Talent Problem — It Has a Strategy Problem Over the past few years, I’ve hired a lot of graduates. I’m a huge believer in...

Pharma Talent Is Global. The Cost Difference is Widening.

Pharma Talent Is Global. The Cost Difference is Widening.

by Andrew Davis

As the US shapes the future of the pharmaceutical industry, how is the EU and UK making the most of its talent?

Join the Pioneer Team at Allerton Bishop

Join the Pioneer Team at Allerton Bishop

by Andrew Davis

Join the Pioneer Team at Allerton Bishop. We are offering equity and buy-in partnership.

2026 Training Program

2026 Training Program

by Andrew Davis

2026 Training Program - Launching in Bishop's Stortford

The Human Reality Behind The Market

The Human Reality Behind The Market

by Andrew Davis

The Human Reality Behind The Market. As we step out of the summer period, there is hope, rather than expectation, that the pharmaceutical market...